Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Ventral Hernia Treatment Market Grown from 2024 to 2025?
The market size for ventral hernia treatment has been on a strong upward trajectory in the past years. The market, which currently stands at $4.87 billion in 2024, is projected to reach $5.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.5%. Factors such as the increased frequency of obesity, heightened knowledge of ventral hernias, an aging population, growing disposable income, and a surge in the need for less invasive surgical procedures have contributed to the historical growth.
What Growth Rate Is Anticipated for the Ventral Hernia Treatment Market in the Coming Years?
In the coming years, the market for ventral hernia treatment is poised to witness significant expansion. The market is projected to reach $6.90 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period can be associated with an increase in outpatient procedures, higher healthcare spending, increased government initiatives, a surge in hernia repair surgeries, and a rise in investment for research and development. The predicted trends during this period include the introduction of advanced hernia repair devices, the use of bioabsorbable materials, strategic collaborations, the utilization of robotic-assisted surgery devices, and remote monitoring systems.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp
Who Are the Leading Companies in the Ventral Hernia Treatment Market?
Major companies operating in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.
What Are the Key Drivers of the Ventral Hernia Treatment Market?
The rise in obesity rates is predicted to fuel the expansion of the ventral hernia treatment market. Characterized by an extreme accumulation of body fat that severely affects a person’s health, obesity rates are on the rise due to factors such as poor nutrition, sedentary habits, genetic predisposition, physical inactivity, environmental factors, and emotional stress. Treatments for ventral hernia can aid those suffering from obesity by addressing the issues caused by excessive weight, including relieving pressure on the abdominal wall, lowering the possibility of hernia relapse, and improving overall abdominal strength. This is vital in boosting mobility and fostering healthier lifestyle decisions among obesity sufferers. To illustrate, the World Health Organization (WHO), based in Switzerland, reported in March 2024 that about one in eight people globally were dealing with obesity. This included 2.5 billion adults aged 18 and over who were overweight, with 890 million among them grappling with obesity. Among the adult population, 43% were deemed overweight, and 16% were categorized as obese. Furthermore, the quantity of overweight children under 5 years reached 37 million. Consequently, the escalating incidence of obesity stimulates the ventral hernia treatment market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21315&type=smp
What Are the Key Market Segments in the Ventral Hernia Treatment Industry?
The ventral hernia treatment market covered in this report is segmented –
1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia
2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)
3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery
4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics
Subsegments:
1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia
2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia
3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia
What Are the Latest Trends in the Ventral Hernia Treatment Market?
Key players in the ventral hernia treatment market are striving for technological innovation, particularly in the field of laparoscopic and open hernia mesh fixation devices, to enhance surgical results, limit complications, and improve patient recovery time. These devices are medical instruments utilized in firming the mesh during hernia repair surgeries, either via minimally invasive (laparoscopic) procedures or traditional open surgical methods. For example, TELA Bio Inc., a medical technology firm based in the U.S., introduced the LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation instruments in the U.S. in March 2024. LIQUIFIX FIX8 is used for minimally invasive repairs and LIQUIFIX precision is designed for open femoral and inguinal hernia repairs. These FDA-approved devices have liquid anchors to secure the mesh without puncturing tissue, significantly reducing risk and complications. As more than 1.2 million hernia procedures take place in the U.S. every year, LIQUIFIX devices ensure precision and safety in delicate regions and significantly reduce the chances of vascular or nerve damage.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report
What Are the Key Regional Markets in the Ventral Hernia Treatment Industry?
North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21315
This Report Delivers Insight On:
1. How big is the ventral hernia treatment market, and how is it changing globally?
2. Who are the major companies in the ventral hernia treatment market, and how are they performing?
3. What are the key opportunities and risks in the ventral hernia treatment market right now?
4. Which products or customer segments are growing the most in the ventral hernia treatment market?
5. What factors are helping or slowing down the growth of the ventral hernia treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model